Barriers Prevent Patient Access to Personalized Therapies Identified by Molecular Tumor Profiling of Gynecologic Malignancies

Barriers Prevent Patient Access to Personalized Therapies Identified by Molecular Tumor Profiling of Gynecologic Malignancies

Objective. This study was designed to evaluate the ability of commercial molecular tumor profiling to discover actionable mutations and to identify barriers that might prevent patient access to personalized therapies. Methods. We conducted an IRB-approved retrospective review of 26 patients with gyn...

Full description

Bibliographic Details
Main Authors: R. Tyler Hillman, Kristy Ward, Cheryl Saenz, Michael McHale, Steven Plaxe
Format: Article
Language:English
Published: MDPI AG 2015-05-01
Series:Journal of Personalized Medicine
Subjects:
targeted therapies
tumor markers
genetics
molecular biology
next generation sequencing
Online Access:http://www.mdpi.com/2075-4426/5/2/165

Internet

http://www.mdpi.com/2075-4426/5/2/165

Similar Items